Valuation: Myomo, Inc.

Market Cap 33.68M 30.69M 28.41M 25.7M 48.21M 3.15B 50.45M 343M 136M 1.7B 126M 124M 5.38B P/E 2026 *
-2.61x
P/E 2027 * -4.24x
Enterprise Value 33.68M 30.69M 28.41M 25.7M 48.21M 3.15B 50.45M 343M 136M 1.7B 126M 124M 5.38B EV / Sales 2026 *
0.72x
EV / Sales 2027 * 0.66x
Free-Float
88.39%
Yield 2026 *
-
Yield 2027 * -
1 day-4.55%
1 week-30.58%
Current month-32.26%
1 month-32.80%
3 months-54.84%
6 months-4.35%
Current year-7.69%
1 week 0.82
Extreme 0.82401
1.22
1 month 0.82
Extreme 0.82401
1.47
Current year 0.6
Extreme 0.605
1.88
1 year 0.6
Extreme 0.605
1.88
3 years 0.6
Extreme 0.605
7.17
5 years 0.37
Extreme 0.369
8.98
10 years 0.37
Extreme 0.369
695.89
Manager TitleAgeSince
Chief Executive Officer 72 2011-06-30
Director of Finance/CFO 64 2019-02-17
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 72 2016-07-31
Director/Board Member 79 2012-02-29
Director/Board Member 80 2014-08-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/13/26 Free

Chief Executive Officer

71,250 0.1799%
10/13/26 Free

Chief Technology Officer

32,500 0.0821%
10/13/26 Free

Chief Financial Officer

51,250 0.1294%
Change 5-day change 1-year change 3-year change Capi.($)
-4.55%-30.58%+16.31%-70.93% 33.68M
-0.58%-3.15%-17.66%+4.34% 180B
-0.11%-0.38%+0.27%+34.58% 123B
-1.59%+0.22%-14.04%+8.57% 119B
-2.21%-1.72%-42.73%-1.44% 89.18B
-2.03%-2.33%-5.40%+75.00% 65.12B
-1.57%-1.40%+11.22%-8.83% 57.93B
-1.26%-1.20%-1.07%+48.73% 54.33B
-2.91%-4.35%-0.82%+38.03% 48.88B
+1.60%+5.04%+4.66%+1.34% 36.07B
Average -1.52%-3.58%-4.93%+12.94% 77B
Weighted average by Cap. -1.14%-1.09%-10.67%+19.20%

Financials

2026 *2027 *
Net sales 46.49M 42.36M 39.21M 35.47M 66.53M 4.34B 69.64M 474M 188M 2.35B 174M 171M 7.43B 51.1M 46.55M 43.09M 38.98M 73.13M 4.77B 76.54M 521M 207M 2.58B 192M 188M 8.17B
Net income -13.8M -12.57M -11.64M -10.53M -19.74M -1.29B -20.67M -141M -55.79M -696M -51.76M -50.68M -2.21B -8.76M -7.98M -7.38M -6.68M -12.53M -818M -13.12M -89.26M -35.41M -442M -32.85M -32.16M -1.4B
Net Debt - -
Projected Income Statement - Annual - Myomo, Inc.
Logo Myomo, Inc.
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
Employees
195
Date Price Change Volume
26-11-19 US$0.8400 -4.55% 429,111
26-11-18 US$0.8800 -4.23% 299,393
26-11-17 US$0.9189 -9.91% 438,688
26-11-16 US$1.020 -17.07% 638,861
26-11-13 US$1.230 +1.65% 390,882
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Myomo, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.8400USD
Average target price
4.640USD
Spread / Average Target
+452.38%